• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 06, 2022 at 11:52: AM
via
  • Pfizer's $6.7 billion acquisition of Arena closed in March and is already bearing fruit.
  • Pfizer recently reported positive results from two phase 3 studies of Arena's etrasimod.
  • Etrasimod has blockbuster potential if approved.

article source
 




Top Bottom
Back
Quote